Literature DB >> 25749903

Clinical characteristics of abnormal savda syndrome type in human immunodeficiency virus infection and acquired immune deficiency syndrome patients: A cross-sectional investigation in Xinjiang, China.

Mi-ji-ti Peierdun1, Wen-xian Liu2, Ai-ze-zi Renaguli2, Amat Nurmuhammat2, Xiao-chun Li3, Ka-ha-er Gulibaier3, Wu-la-mu Ainivaer3, Upur Halmurat4.   

Abstract

OBJECTIVE: To investigate the distribution of abnormal hilit syndromes in traditional Uighur medicine (TUM) among human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) patients, and to find out the clinical characteristics of abnormal savda syndrome type HIV/AIDS patients.
METHODS: Between June and July in 2012, 307 eligible HIV/AIDS patients from in-patient department and out-patient clinics of Xinjiang Uighur Autonomous Region the Sixth People's Hospital in Urumqi were investigated. TUM syndrome differentiation was performed by a senior TUM physician. Each participant completed a Sign and Symptom Check-List for Persons Living with HIV/AIDS (SSC-HIV) questionnaire. Depression was evaluated by using Hamilton Rating Scale for Depression Questionnaire. Blood specimen was collected from each participant to test the levels of blood chemicals.
RESULTS: Of 307 HIV/AIDS patients, 189 (61.6%) were abnormal savda syndrome type, 118 (38.4%) were non-abnormal-savda syndrome type. Mean CD4 counts of abnormal savda syndrome type patients was (227.61±192.93) cells/µL, and the prevalence of anemia, thrombocytopenia, and elevated cystatin C were 49.7%, 28.6%, and 44.7%, which were significantly higher than those in the non-abnormal-savda syndrome type patients (26.3%, 16.0% and 25.0%,P<0.05). In addition, depression (79.9%) and HIV/AIDS-related symptoms such as fatigue (42.3%), back aches (40.7%), lack of appetite (33.9%), night sweats (31.7%) were more common among abnormal savda syndrome patients (P<0.05).
CONCLUSION: Abnormal savda syndrome is the dominant syndrome among HIV/AIDS patients, and they present a more sever clinical manifestation.

Entities:  

Keywords:  abnormal savda syndrome; depression; human immunodeficiency virus infection and acquired immune deficiency syndrome; symptoms; traditional Uighur medicine

Mesh:

Year:  2015        PMID: 25749903     DOI: 10.1007/s11655-015-2075-8

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   2.626


  11 in total

1.  Correlative analysis of neoplasm patients with phlegm-stasis or abnormal Savda syndrome, based on metabonomics.

Authors:  Mamtimin Batur; Upur Halmurat; Fu-Hua Hao; Rena Aiziz; Matsidik Aynur
Journal:  J Tradit Chin Med       Date:  2012-03       Impact factor: 0.848

2.  Uighur traditional medicine syndrome of Abnormal Savda in men is associated with oxidative stress, which can be improved by Munziq and Mushil of Abnormal Savda.

Authors:  Halmurat Upur; Abdiryim Yusup; Anwar Umar; Nicholas Moore
Journal:  Therapie       Date:  2004 Jul-Aug       Impact factor: 2.070

Review 3.  Contribution of traditional medicine in the healthcare system of the Middle East.

Authors:  Erdem Yesilada
Journal:  Chin J Integr Med       Date:  2011-03-09       Impact factor: 1.978

4.  Abnormal Savda syndrome: long-term consequences of emotional and physical stress on endocrine and immune activities in an animal model.

Authors:  Adiljan Ablimit; Harald Kühnel; Alois Strasser; Halmurat Upur
Journal:  Chin J Integr Med       Date:  2012-05-19       Impact factor: 1.978

5.  Evidence-based clinical practice guidelines for managing depression in persons living with HIV.

Authors:  Michael V Relf; Shelly Eisbach; Kayj Nash Okine; Terry Ward
Journal:  J Assoc Nurses AIDS Care       Date:  2013 Jan-Feb       Impact factor: 1.354

Review 6.  A guiding tool in Unani Tibb for maintenance and preservation of health: a review study.

Authors:  Farkhunda Jabin
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-07-03

7.  Percentage reduction of depression severity versus absolute severity after initial weeks of treatment to predict final response or remission.

Authors:  Ching-Hua Lin; Cheng-Chung Chen; Fu-Chiang Wang; Hsien-Yuan Lane
Journal:  Psychiatry Clin Neurosci       Date:  2013-05       Impact factor: 5.188

8.  Validation of a Chinese version of the sign and symptom checklist for persons with HIV diseases.

Authors:  Yun-Fang Tsai; Ping-Chuan Hsiung; William L Holzemer
Journal:  J Pain Symptom Manage       Date:  2003-04       Impact factor: 3.612

9.  Assessment of haematological parameters in HIV-infected and uninfected Rwandan women: a cross-sectional study.

Authors:  Elisaphane Munyazesa; Ivan Emile; Eugene Mutimura; Donald R Hoover; Qiuhu Shi; Aileen P McGinn; Stephenson Musiime; Fred Muhairwe; Alfred Rutagengwa; Jean Claude Dusingize; Kathryn Anastos
Journal:  BMJ Open       Date:  2012-11-20       Impact factor: 2.692

10.  Magnesium deficiency induces anxiety and HPA axis dysregulation: modulation by therapeutic drug treatment.

Authors:  S B Sartori; N Whittle; A Hetzenauer; N Singewald
Journal:  Neuropharmacology       Date:  2011-08-04       Impact factor: 5.250

View more
  2 in total

Review 1.  News from Tartary: an ethnopharmacological approach to drug and therapeutic discovery.

Authors:  Nicholas Moore; Nawel Hamza; Benedicte Berke; Anwar Umar
Journal:  Br J Clin Pharmacol       Date:  2016-07-24       Impact factor: 4.335

2.  Prevalence of anemia among people living with HIV: A systematic review and meta-analysis.

Authors:  Guiying Cao; Yaping Wang; Yu Wu; Wenzhan Jing; Jue Liu; Min Liu
Journal:  EClinicalMedicine       Date:  2022-01-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.